Cargando…

Reduction of Cardiac Autonomic Modulation and Increased Sympathetic Activity by Heart Rate Variability in Patients With Long COVID

Although several clinical manifestations of persistent long coronavirus disease (COVID-19) have been documented, their effects on the cardiovascular and autonomic nervous system over the long term remain unclear. Thus, we examined the presence of alterations in cardiac autonomic functioning in indiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Marques, Karina Carvalho, Silva, Camilla Costa, Trindade, Steffany da Silva, Santos, Márcio Clementino de Souza, Rocha, Rodrigo Santiago Barbosa, Vasconcelos, Pedro Fernando da Costa, Quaresma, Juarez Antônio Simões, Falcão, Luiz Fábio Magno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098798/
https://www.ncbi.nlm.nih.gov/pubmed/35571200
http://dx.doi.org/10.3389/fcvm.2022.862001
_version_ 1784706457863716864
author Marques, Karina Carvalho
Silva, Camilla Costa
Trindade, Steffany da Silva
Santos, Márcio Clementino de Souza
Rocha, Rodrigo Santiago Barbosa
Vasconcelos, Pedro Fernando da Costa
Quaresma, Juarez Antônio Simões
Falcão, Luiz Fábio Magno
author_facet Marques, Karina Carvalho
Silva, Camilla Costa
Trindade, Steffany da Silva
Santos, Márcio Clementino de Souza
Rocha, Rodrigo Santiago Barbosa
Vasconcelos, Pedro Fernando da Costa
Quaresma, Juarez Antônio Simões
Falcão, Luiz Fábio Magno
author_sort Marques, Karina Carvalho
collection PubMed
description Although several clinical manifestations of persistent long coronavirus disease (COVID-19) have been documented, their effects on the cardiovascular and autonomic nervous system over the long term remain unclear. Thus, we examined the presence of alterations in cardiac autonomic functioning in individuals with long-term manifestations. The study was conducted from October 2020 to May 2021, and an autonomic assessment was performed to collect heart rate data for the heart rate variability (HRV) analysis. The study participants were divided into the long COVID clinical group, the intragroup, which included patients who were hospitalized, and those who were not hospitalized and were symptomatic for different periods (≤3, >3, ≤6, and >6 months), with and without dyspnoea. The control group, the intergroup, comprised of COVID-free individuals. Our results demonstrated that the long COVID clinical group showed reduced HRV compared with the COVID-19-uninfected control group. Patients aged 23–59 years developed COVID symptoms within 30 days after infection, whose diagnosis was confirmed by serologic or reverse-transcription polymerase chain reaction (swab) tests, were included in the study. A total of 155 patients with long COVID [95 women (61.29%), mean age 43.88 ± 10.88 years and 60 men (38.71%), mean age 43.93 ± 10.11 years] and 94 controls [61 women (64.89%), mean age 40.83 ± 6.31 and 33 men (35.11%), mean age 40.69 ± 6.35 years] were included. The intragroup and intergroup comparisons revealed a reduction in global HRV, increased sympathetic modulation influence, and a decrease in parasympathetic modulation in long COVID. The intragroup showed normal sympathovagal balance, while the intergroup showed reduced sympathovagal balance. Our findings indicate that long COVID leads to sympathetic excitation influence and parasympathetic reduction. The excitation can increase the heart rate and blood pressure and predispose to cardiovascular complications. Short-term HRV analysis showed good reproducibility to verify the cardiac autonomic involvement.
format Online
Article
Text
id pubmed-9098798
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90987982022-05-14 Reduction of Cardiac Autonomic Modulation and Increased Sympathetic Activity by Heart Rate Variability in Patients With Long COVID Marques, Karina Carvalho Silva, Camilla Costa Trindade, Steffany da Silva Santos, Márcio Clementino de Souza Rocha, Rodrigo Santiago Barbosa Vasconcelos, Pedro Fernando da Costa Quaresma, Juarez Antônio Simões Falcão, Luiz Fábio Magno Front Cardiovasc Med Cardiovascular Medicine Although several clinical manifestations of persistent long coronavirus disease (COVID-19) have been documented, their effects on the cardiovascular and autonomic nervous system over the long term remain unclear. Thus, we examined the presence of alterations in cardiac autonomic functioning in individuals with long-term manifestations. The study was conducted from October 2020 to May 2021, and an autonomic assessment was performed to collect heart rate data for the heart rate variability (HRV) analysis. The study participants were divided into the long COVID clinical group, the intragroup, which included patients who were hospitalized, and those who were not hospitalized and were symptomatic for different periods (≤3, >3, ≤6, and >6 months), with and without dyspnoea. The control group, the intergroup, comprised of COVID-free individuals. Our results demonstrated that the long COVID clinical group showed reduced HRV compared with the COVID-19-uninfected control group. Patients aged 23–59 years developed COVID symptoms within 30 days after infection, whose diagnosis was confirmed by serologic or reverse-transcription polymerase chain reaction (swab) tests, were included in the study. A total of 155 patients with long COVID [95 women (61.29%), mean age 43.88 ± 10.88 years and 60 men (38.71%), mean age 43.93 ± 10.11 years] and 94 controls [61 women (64.89%), mean age 40.83 ± 6.31 and 33 men (35.11%), mean age 40.69 ± 6.35 years] were included. The intragroup and intergroup comparisons revealed a reduction in global HRV, increased sympathetic modulation influence, and a decrease in parasympathetic modulation in long COVID. The intragroup showed normal sympathovagal balance, while the intergroup showed reduced sympathovagal balance. Our findings indicate that long COVID leads to sympathetic excitation influence and parasympathetic reduction. The excitation can increase the heart rate and blood pressure and predispose to cardiovascular complications. Short-term HRV analysis showed good reproducibility to verify the cardiac autonomic involvement. Frontiers Media S.A. 2022-04-29 /pmc/articles/PMC9098798/ /pubmed/35571200 http://dx.doi.org/10.3389/fcvm.2022.862001 Text en Copyright © 2022 Marques, Silva, Trindade, Santos, Rocha, Vasconcelos, Quaresma and Falcão. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Marques, Karina Carvalho
Silva, Camilla Costa
Trindade, Steffany da Silva
Santos, Márcio Clementino de Souza
Rocha, Rodrigo Santiago Barbosa
Vasconcelos, Pedro Fernando da Costa
Quaresma, Juarez Antônio Simões
Falcão, Luiz Fábio Magno
Reduction of Cardiac Autonomic Modulation and Increased Sympathetic Activity by Heart Rate Variability in Patients With Long COVID
title Reduction of Cardiac Autonomic Modulation and Increased Sympathetic Activity by Heart Rate Variability in Patients With Long COVID
title_full Reduction of Cardiac Autonomic Modulation and Increased Sympathetic Activity by Heart Rate Variability in Patients With Long COVID
title_fullStr Reduction of Cardiac Autonomic Modulation and Increased Sympathetic Activity by Heart Rate Variability in Patients With Long COVID
title_full_unstemmed Reduction of Cardiac Autonomic Modulation and Increased Sympathetic Activity by Heart Rate Variability in Patients With Long COVID
title_short Reduction of Cardiac Autonomic Modulation and Increased Sympathetic Activity by Heart Rate Variability in Patients With Long COVID
title_sort reduction of cardiac autonomic modulation and increased sympathetic activity by heart rate variability in patients with long covid
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098798/
https://www.ncbi.nlm.nih.gov/pubmed/35571200
http://dx.doi.org/10.3389/fcvm.2022.862001
work_keys_str_mv AT marqueskarinacarvalho reductionofcardiacautonomicmodulationandincreasedsympatheticactivitybyheartratevariabilityinpatientswithlongcovid
AT silvacamillacosta reductionofcardiacautonomicmodulationandincreasedsympatheticactivitybyheartratevariabilityinpatientswithlongcovid
AT trindadesteffanydasilva reductionofcardiacautonomicmodulationandincreasedsympatheticactivitybyheartratevariabilityinpatientswithlongcovid
AT santosmarcioclementinodesouza reductionofcardiacautonomicmodulationandincreasedsympatheticactivitybyheartratevariabilityinpatientswithlongcovid
AT rocharodrigosantiagobarbosa reductionofcardiacautonomicmodulationandincreasedsympatheticactivitybyheartratevariabilityinpatientswithlongcovid
AT vasconcelospedrofernandodacosta reductionofcardiacautonomicmodulationandincreasedsympatheticactivitybyheartratevariabilityinpatientswithlongcovid
AT quaresmajuarezantoniosimoes reductionofcardiacautonomicmodulationandincreasedsympatheticactivitybyheartratevariabilityinpatientswithlongcovid
AT falcaoluizfabiomagno reductionofcardiacautonomicmodulationandincreasedsympatheticactivitybyheartratevariabilityinpatientswithlongcovid